Detalles de la búsqueda
1.
Clinical implications of non-breast cancer related findings on FDG-PET/CT scan prior to neoadjuvant chemotherapy in patients with breast cancer.
Breast Cancer Res Treat
; 2024 Jun 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-38864980
2.
Advances in Radionuclide Therapies for Patients with Neuro-endocrine Tumors.
Curr Oncol Rep
; 26(5): 551-561, 2024 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-38598035
3.
The effect of long-acting somatostatin analogues on the uptake of [177Lu]Lu-HA-DOTATATE.
Eur J Nucl Med Mol Imaging
; 50(5): 1434-1441, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36598536
4.
Incidence of PSMA PET thyroid incidentaloma depends on analysis method and tracer.
Eur Radiol
; 33(5): 3377-3385, 2023 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-36892644
5.
Three-year follow-up of de-escalated axillary treatment after neoadjuvant systemic therapy in clinically node-positive breast cancer: the MARI-protocol.
Breast Cancer Res Treat
; 193(1): 37-48, 2022 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-35239072
6.
68Ga-PSMA Cerenkov luminescence imaging in primary prostate cancer: first-in-man series.
Eur J Nucl Med Mol Imaging
; 47(11): 2624-2632, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32242253
7.
Clinical impact of PSMA PET/CT in primary prostate cancer compared to conventional nodal and distant staging: a retrospective single center study.
BMC Cancer
; 20(1): 723, 2020 Aug 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-32758168
8.
The use of FDG-PET/CT to detect early recurrence after resection of high-risk stage III melanoma.
J Surg Oncol
; 122(7): 1328-1336, 2020 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-32783266
9.
177 Lutetium SPECT/CT: Evaluation of collimator, photopeak and scatter correction.
J Appl Clin Med Phys
; 21(9): 272-277, 2020 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-32790140
10.
Sentinel lymph node nonvisualization after intratumoral radioisotope tracer injection in breast cancer is not associated with a higher nodal metastasis rate or worse outcomes.
J Surg Oncol
; 119(4): 421-429, 2019 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30582611
11.
Hybrid training in nuclear medicine: where are we going to?
Eur J Nucl Med Mol Imaging
; 50(8): 2231-2235, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37052628
12.
Vemurafenib plus cobimetinib in unresectable stage IIIc or stage IV melanoma: response monitoring and resistance prediction with positron emission tomography and tumor characteristics (REPOSIT): study protocol of a phase II, open-label, multicenter study.
BMC Cancer
; 17(1): 649, 2017 Sep 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-28915798
13.
Follow-up of patients with thyroglobulin-antibodies: Rising Tg-Ab trend is a risk factor for recurrence of differentiated thyroid cancer.
Endocr Res
; 42(4): 302-310, 2017 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-28509618
14.
Evaluation of a Hanging-Breast PET System for Primary Tumor Visualization in Patients With Stage I-III Breast Cancer: Comparison With Standard PET/CT.
AJR Am J Roentgenol
; 206(6): 1307-14, 2016 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-27058014
15.
Heading toward radioactive seed localization in non-palpable breast cancer surgery? A meta-analysis.
J Surg Oncol
; 111(2): 185-91, 2015 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-25195916
16.
Recurrent differentiated thyroid cancer: towards personalized treatment based on evaluation of tumor characteristics with PET (THYROPET Study): study protocol of a multicenter observational cohort study.
BMC Cancer
; 14: 405, 2014 Jun 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-24906384
17.
Radio-Guided Occult Lesion Localization With 99m Tc for the Localization of Nonpalpable Melanoma and Soft Tissue Sarcoma Lesions: A Feasibility Study.
Clin Nucl Med
; 49(1): 23-26, 2024 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37991434
18.
Baseline and on Treatment Biodistribution Variability of 18F-FLT Uptake in Patients With Advanced Melanoma: Brief Communication.
Clin Nucl Med
; 2024 May 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-38768063
19.
The Predictive Value of FDG PET/CT for Determining Progression-Free Survival in Advanced Stage III-IV BRAF -Mutated Melanoma Patients Treated With Targeted Therapy-What Can Be Learned From Progression?
Clin Nucl Med
; 49(2): 138-145, 2024 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38113329
20.
Predicting [177Lu]Lu-HA-DOTATATE kidney and tumor accumulation based on [68Ga]Ga-HA-DOTATATE diagnostic imaging using semi-physiological population pharmacokinetic modeling.
EJNMMI Phys
; 10(1): 48, 2023 Aug 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-37615812